1 insider bought €13k of shares over the last 90 days, the latest filed 12 Aug 2026.
C-RAD AB, classified in the Health Care sector, is a listed company. Its insiders report their share dealings to Finansinspektionen. 6 insiders have disclosed 14 filings since 18 October 2025.
On the market, 6 insiders bought (12 purchases totalling €540k) while 1 insider sold (2 sales totalling €13k). The net balance comes to €527k on the buying side. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The largest single trade was a purchase of €184k by Tomas Blomquist, published on 10 June 2026, equal to 0.17% of the market capitalisation. Among those who bought: 3 chief executives, 2 board members and 1 finance chief.
In all, 5 purchases were made within 30 days of a purchase by another insider of the company. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time. The latest purchase dates back some time: it was published 66 days ago, on 12 August 2026. Filings reach the Finansinspektionen feed a median of 2 days after the trade. Under the Market Abuse Regulation, managers have three business days to notify their trades.
For context, the typical company on the same exchange (median of 885 companies) published 7 filings over the same period, against 14 filings here. Looking back to 2025, when coverage begins, insiders filed 13 purchases and 2 sales.
Other companies in the same sector with recent insider buying flagged by our signals: MAIA Biotechnology, Inc. and Cooper Companies, Inc. Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.
Analysts rate C-RAD AB Buy (bullish), based on 1 analysts. Average price target: SEK 42.00.
Transparent value + quality ranking, distinct from the insider signal.
FY ended December 2025 · cache
15 of 15 declarations
C-RAD AB is a company focused on developing positioning and monitoring solutions for radiation therapy. It is listed on the Stockholm Stock Exchange.